Anticoagulants Market

Anticoagulants Market Size, Share, Growth 2024-2032

The new report by Expert Market Research titled, ‘Global Anticoagulants Market Share, Size, Trends, Growth, Scope, Report and Forecast 2024-2032’, gives an in-depth analysis of the global anticoagulants market, assessing the market based on its segments like drug class, applications, and major regions.

The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

The key highlights of the report include:

Market Overview (2016-2032)

  • Historical Market Size (2023): USD 34.8 billion
  • Forecast CAGR (2024-2032): 8.2%
  • Forecast Market Size (2032): USD 70.9 billion

Growing lifestyle hazards such as diabetes and obesity, as well as public health awareness, require more effective and efficient therapies. Anticoagulant use and expense have increased dramatically since the advent of NOACs. Anticoagulant production and efficiency are increasing as pharmaceutical and therapeutic industries improve. Anticoagulant sales are increasing as a result of this. COVID-19’s health concerns and threats have prompted increased investment in the anticoagulant business. The government’s increasing healthcare spending, as well as that of important industry players, is a major driving force in the market. Anticoagulant safety and dose are subject to stringent government regulations. The FDA’s approval of anticoagulants for paediatric cardiac patients in 2019 is also a significant boon for the sector.

Anticoagulants Definition and Major Segments

Anticoagulants are medications that help to prevent blood clots from forming. They’re given to those who have a high risk of blood clots in order to assist them prevent serious illnesses including strokes and heart attacks. Anticoagulants work by preventing blood clots from forming in the first place.

Explore the full report with the table of contents@

Based on drug class, the market can be bifurcated into:

• Novel Oral Anticoagulants (NOACs)
• Heparin and Low Molecular Weight Heparin (LMWH)
• Vitamin K Antagonist

Based on application, the market can be broadly segmented into:

• Atrial Fibrillation/Myocardial Infarction (Heart Attack)
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism
• Others

On the Basis of region, the market can be divided into:

• North America
• Europe
• The Asia Pacific
• Latin America
• The Middle East and Africa

Latest News on Global Anticoagulants Market@

Anticoagulants Market Trends

One of the most important markets for anticoagulants is North America. The increase in the incidence rate of cardiovascular diseases in North America is to blame for this. According to the Centers for Disease Control and Prevention, heart disease is responsible for one out of every four deaths in the United States, resulting in approximately 655,000 deaths per year. Furthermore, the existence of significant pharma and biotech businesses, as well as a well-established healthcare infrastructure, is assisting the regional market’s expansion to a large extent.

The anticoagulants sector is likewise heavily influenced by Europe. According to 2019 estimates from the European Society of Cardiology (ESC), the region sees more than 11 million new cases of cardiovascular diseases (CVD) each year. Approximately 49 million people in the EU suffer from this illness. CVD is also the biggest cause of death in Europe, according to the ESC, accounting for around 45 percent of all deaths and 37 percent in the EU. Meanwhile, large Asian countries, such as China, are seeing an increase in CVD cases. China is seeing an increase in the number of people dying from cardiovascular disease. Cardiovascular disease (CVD) was the leading cause of death in both rural and urban areas in 2016, according to the Journal of Geriatric Cardiology, accounting for 45.50 percent and 43.16 percent of all deaths, respectively. In the forecast period, China is likely to become a developing market for anticoagulants.

Key Market Players

The major players in the market are Johnson & Johnson Services Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, GlaxoSmithKline plc, Aspen Pharmacare Holdings Limited, Pfizer Inc., Portola Pharmaceuticals Inc., and Others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today’s competitive market.

Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation’s future success by acquiring one of our Expert Market Research reports today.

Media Contact:

Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *